Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Mitral Stenosis III: Medical Management01:26

Mitral Stenosis III: Medical Management

398
Mitral stenosis, a condition marked by the narrowing of the mitral valve, necessitates an integrated approach for effective management. This approach includes preventative measures, medical therapy, and surgical interventions to reduce symptoms and prevent complications.PreventionPrevention of mitral stenosis primarily focuses on reducing the incidence of bacterial infections, particularly streptococcal infections, which can lead to rheumatic fever and subsequent valvular damage. Timely...
398
Mitral Regurgitation III: Medical Management01:25

Mitral Regurgitation III: Medical Management

475
Mitral regurgitation (MR) is characterized by retrograde blood circulation from the left ventricle into the left atrium due to inadequate mitral valve closure. The severity of the condition, symptoms, and underlying cause determine treatment strategies.Monitoring and Pharmacological TreatmentPatients with mild to moderate MR typically do not need immediate intervention but regular monitoring to assess progression and guide treatment. Patients with mild MR should have an echocardiogram every 3-5...
475
Aortic Regurgitation III: Medical Management01:25

Aortic Regurgitation III: Medical Management

528
Aortic regurgitation (AR) is when the aortic valve does not close or seal properly, leading to backward blood circulation from the aorta into the left ventricle during diastole. Common causes of AR include rheumatic heart disease, congenital valve defects, and aortic root dilation. Managing AR requires a multifaceted approach to alleviate symptoms, preserve left ventricular function, and address the underlying cause of the regurgitation. Patients with symptomatic AR or significant left...
528
Mitral Valve Prolapse II: Assessment and Management01:22

Mitral Valve Prolapse II: Assessment and Management

898
IntroductionA range of clinical features characterizes Mitral Valve Prolapse (MVP), but it is important to note that many individuals with MVP are asymptomatic and may remain so throughout their lives. For those who do exhibit symptoms, the following are the key clinical features:Palpitations: This is a common symptom where individuals feel an irregular or rapid heartbeat. Palpitations in MVP are often due to arrhythmias such as premature ventricular contractions or supraventricular...
898
Mitral Regurgitation IV: Nursing Management01:28

Mitral Regurgitation IV: Nursing Management

455
Mitral regurgitation (MR) is a condition where the mitral valve does not close properly, leading to the backward flow of blood from the left ventricle into the left atrium during systole. This condition can arise from various causes, including rheumatic fever, infective endocarditis, or degenerative valve disease. Effective nursing management is crucial to optimizing patient outcomes and involves comprehensive assessment and targeted interventions.Comprehensive Patient AssessmentA detailed...
455
Mitral Valve Prolapse III: Nursing Management01:19

Mitral Valve Prolapse III: Nursing Management

498
The nursing management of Mitral Valve Prolapse, or MVP, centers around patient education, symptom monitoring, and lifestyle modifications.Patient Education on MVP Diagnosis and Heredity: Nurses should provide comprehensive education about MVP, a condition where the mitral valve does not close appropriately during heartbeats. This education often includes the condition's pathophysiology, symptoms, and potential complications, like arrhythmias or mitral regurgitation. Though not fully...
498

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Development and implementation of a severe accidental hypothermia resuscitation pathway in an urban Canadian emergency department: a quality improvement initiative.

CJEM·2026
Same author

Contemporary practice patterns and outcomes of isolated tricuspid valve surgery in North America: systematic review with meta-analysis.

Annals of cardiothoracic surgery·2026
Same author

Prehabilitation in cardiac surgery.

JTCVS open·2026
Same author

Navigating isolated tricuspid regurgitation: A practical guide to perioperative and periprocedural management.

JTCVS open·2026
Same author

An Unusual Case of Cardiac Tamponade From a Foreign Body.

JACC. Case reports·2026
Same author

Relationship Between Achieved LDL-C and Saphenous Vein Graft Patency: A Post Hoc Analysis of the NEWTON-CABG CardioLink-5 Study.

European journal of preventive cardiology·2026

Related Experiment Video

Updated: Mar 9, 2026

Transcatheter Pulmonary Valve Replacement from Autologous Pericardium with a Self-Expandable Nitinol Stent in an Adult Sheep Model
05:31

Transcatheter Pulmonary Valve Replacement from Autologous Pericardium with a Self-Expandable Nitinol Stent in an Adult Sheep Model

Published on: June 8, 2022

3.5K

Innovations in tricuspid valve intervention.

Ahmed El-Eshmawi1, Gilbert H L Tang, Subodh Verma

  • 1aDepartment of Cardiovascular Surgery, Mount Sinai Medical Center, New York, New York, USA bDivision of Cardiac Surgery, St Michael's Hospital, Toronto cDivision of Cardiac Surgery, Ottawa Heart Institute, Ottawa, Ontario, Canada.

Current Opinion in Cardiology
|January 10, 2017
PubMed
Summary

Tricuspid valve disease is now recognized as significant, with new guidelines recommending aggressive treatment. Both surgical and transcatheter interventions are emerging as effective options for patients with tricuspid regurgitation.

More Related Videos

A Simplified Stepwise Approach to Echo Guidance during Percutaneous Mitral Valve Repair
08:31

A Simplified Stepwise Approach to Echo Guidance during Percutaneous Mitral Valve Repair

Published on: October 16, 2021

4.5K
Cox-Maze IV Procedure Concomitant with Valvular Surgery In Situs Inversus Dextrocardia: A Single-Center Experience in China
08:42

Cox-Maze IV Procedure Concomitant with Valvular Surgery In Situs Inversus Dextrocardia: A Single-Center Experience in China

Published on: February 11, 2022

4.4K

Related Experiment Videos

Last Updated: Mar 9, 2026

Transcatheter Pulmonary Valve Replacement from Autologous Pericardium with a Self-Expandable Nitinol Stent in an Adult Sheep Model
05:31

Transcatheter Pulmonary Valve Replacement from Autologous Pericardium with a Self-Expandable Nitinol Stent in an Adult Sheep Model

Published on: June 8, 2022

3.5K
A Simplified Stepwise Approach to Echo Guidance during Percutaneous Mitral Valve Repair
08:31

A Simplified Stepwise Approach to Echo Guidance during Percutaneous Mitral Valve Repair

Published on: October 16, 2021

4.5K
Cox-Maze IV Procedure Concomitant with Valvular Surgery In Situs Inversus Dextrocardia: A Single-Center Experience in China
08:42

Cox-Maze IV Procedure Concomitant with Valvular Surgery In Situs Inversus Dextrocardia: A Single-Center Experience in China

Published on: February 11, 2022

4.4K

Area of Science:

  • Cardiology
  • Cardiac Surgery
  • Interventional Cardiology

Background:

  • Tricuspid valve disease historically received limited attention, often considered secondary to left-sided valve issues.
  • The belief that left-sided valve treatment resolves functional tricuspid regurgitation is being challenged by new data.
  • Tricuspid regurgitation is increasingly recognized as a condition that can negatively impact patient outcomes.

Purpose of the Study:

  • To review the latest surgical and interventional options for tricuspid valve disease.
  • To highlight evolving strategies for managing moderate to severe tricuspid regurgitation.
  • To discuss the treatment of isolated tricuspid dilatation as a prophylactic measure.

Main Methods:

  • Review of current clinical guidelines and recent literature on tricuspid valve interventions.
  • Description of surgical techniques, including annuloplasty and newer ring devices.
  • Overview of emerging transcatheter therapies for high-risk surgical patients.

Main Results:

  • Updated guidelines advocate for a more aggressive surgical approach to moderate/severe tricuspid regurgitation, favoring annuloplasty.
  • Prophylactic treatment of isolated significant tricuspid dilatation is now recommended.
  • Development of novel tricuspid annuloplasty rings and early positive experiences with transcatheter repair devices.

Conclusions:

  • Recent advancements in surgical and transcatheter treatments offer promising solutions for tricuspid valve disease.
  • These innovations aim to address the historical neglect of the tricuspid valve in clinical practice.
  • The 'forgotten valve' may soon be recognized and treated more effectively.